QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:CLSH

CLS Holdings USA (CLSH) Stock Price, News & Analysis

$0.06
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
$0.06
$0.06
50-Day Range
$0.04
$0.06
52-Week Range
$0.03
$0.12
Volume
2,000 shs
Average Volume
120,404 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CLSH stock logo

About CLS Holdings USA Stock (OTCMKTS:CLSH)

CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators. It offers its products under Oasis Cannabis and City Trees brand names. The company's concentrates are used for pharmaceutical and other purposes. CLS Holdings USA, Inc. was founded in 2014 and is based in Las Vegas, Nevada.

CLSH Stock Price History

CLSH Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
CLS Holdings USA, Inc. (CLSH)
CLS Holdings USA Inc CLSH
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
CLS Holdings USA reports Q1 results
CLS Reports Fiscal First Quarter 2024 Financial Results
CLS Holdings USA, Inc. 2023 CEO Address to Shareholders
Oasis Employee Appreciation Month for August 2023
Oasis Cannabis Launches VIP Loyalty Program
See More Headlines
Receive CLSH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CLS Holdings USA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:CLSH
Fax
N/A
Employees
86
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Andrew J. Glashow (Age 61)
    CEO, President, Principal Financial & Accounting Officer, Secretary and Chairman
    Comp: $300.72k
  • Dr. Dominick Monaco (Age 44)
    Chief Science Officer
    Comp: $177.42k
  • Ms. Charlene Soco (Age 33)
    Executive Vice President of Finance
    Comp: $175.69k
  • Ms. Jamie Dickson (Age 46)
    Chief Administrative Officer & Secretary

CLSH Stock Analysis - Frequently Asked Questions

How have CLSH shares performed in 2024?

CLS Holdings USA's stock was trading at $0.0425 on January 1st, 2024. Since then, CLSH stock has increased by 29.4% and is now trading at $0.0550.
View the best growth stocks for 2024 here
.

Are investors shorting CLS Holdings USA?

CLS Holdings USA saw a increase in short interest in March. As of March 31st, there was short interest totaling 42,700 shares, an increase of 119.0% from the March 15th total of 19,500 shares. Based on an average daily volume of 107,000 shares, the short-interest ratio is presently 0.4 days.
View CLS Holdings USA's Short Interest
.

What other stocks do shareholders of CLS Holdings USA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CLS Holdings USA investors own include Fulcrum Therapeutics (FULC), iAnthus Capital (ITHUF), KushCo (KSHB), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Charlotte's Web (CWBHF), Kaleido Biosciences (KLDO) and Planet 13 (PLNHF).

How do I buy shares of CLS Holdings USA?

Shares of CLSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLSH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners